Preparation and evaluation of bufalin and quercetin co-loaded nanoparticles for the treatment of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) incidence and mortality are rising, and current treatments have limitations. Novel liver-targeted drug delivery systems have thus emerged as a viable approach for HCC treatment, and combining two or more synergistic drugs represents an effective therapeutic strategy. In this study, the optimal synergistic ratio of bufalin (BF) and quercetin (QUE) was determined by MTT assay and combination index (CI) analysis to be 4:3 (mass ratio). A conjugate of Angelica sinensis polysaccharide (ASP) and ursodeoxycholic acid (UDCA) was synthesized as a carrier, and novel pH-responsive hepatic-targeted nanoparticles co-delivering BF and QUE at the optimal ratio (BF-QUE/ASP-UDCA NPs) were successfully fabricated, with a mean diameter of 166.57 ± 2.7 nm and a zeta potential of -8.83 ± 0.109 mV. The NPs exhibited good stability, pH-dependent release, enhanced cellular uptake, and higher inhibition rates. Importantly, BF, QUE, and UDCA displayed synergistic anti‑HCC effects. In H22 tumor-bearing mice, the BF-QUE/ASP-UDCA NPs group achieved a tumor inhibition rate of 72.24% and could exert antitumor activity by modulating immune function in mice. Collectively, BF‑QUE/ASP‑UDCA NPs show liver targeting and synergistic anti‑HCC efficacy, making them a promising nanocarrier system for liver tumor therapy.

Authors

Institutions

Publication Details

Journal
Journal of drug targeting
Published
2026-11-16
DOI
https://doi.org/10.1080/1061186x.2026.2765327
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Preparation and evaluation of bufalin and quercetin co-loaded nanoparticles for the treatment of hepatocellular carcinoma

Wenna Shao, Yan Sun, 盛华刚, Jiali Li et al.
5 links
Journal of drug targeting
Nanoparticle-Based Drug Delivery
article

Preparation and evaluation of bufalin and quercetin co-loaded nanoparticles for the treatment of hepatocellular carcinoma

Wenna Shao, Yan Sun, 盛华刚, Jiali Li, Tiantian Zhu, Chengcheng Gao, Liqiao Zhu
article en

Abstract

Hepatocellular carcinoma (HCC) incidence and mortality are rising, and current treatments have limitations. Novel liver-targeted drug delivery systems have thus emerged as a viable approach for HCC treatment, and combining two or more synergistic drugs represents an effective therapeutic strategy. In this study, the optimal synergistic ratio of bufalin (BF) and quercetin (QUE) was determined by MTT assay and combination index (CI) analysis to be 4:3 (mass ratio). A conjugate of Angelica sinensis polysaccharide (ASP) and ursodeoxycholic acid (UDCA) was synthesized as a carrier, and novel pH-responsive hepatic-targeted nanoparticles co-delivering BF and QUE at the optimal ratio (BF-QUE/ASP-UDCA NPs) were successfully fabricated, with a mean diameter of 166.57 ± 2.7 nm and a zeta potential of -8.83 ± 0.109 mV. The NPs exhibited good stability, pH-dependent release, enhanced cellular uptake, and higher inhibition rates. Importantly, BF, QUE, and UDCA displayed synergistic anti‑HCC effects. In H22 tumor-bearing mice, the BF-QUE/ASP-UDCA NPs group achieved a tumor inhibition rate of 72.24% and could exert antitumor activity by modulating immune function in mice. Collectively, BF‑QUE/ASP‑UDCA NPs show liver targeting and synergistic anti‑HCC efficacy, making them a promising nanocarrier system for liver tumor therapy.

Journal of drug targeting
Shandong University of Traditional Chinese Medicine (CN)
Good health and well-being
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon